| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/05/2008 | CN101134107A Antithrombotic agents |
| 03/05/2008 | CN101134106A Pharmaceutical composition containing human urine kininogenase for treating cerebral infarction |
| 03/05/2008 | CN101134105A Pharmaceutical composition containing recombination human pancreatic kininogenase for treating and/or preventing cerebral infarction |
| 03/05/2008 | CN101134099A Traditional Chinese medicine for treating megrim caused by vertebra- fundus artery blood supply insufficiency |
| 03/05/2008 | CN101134087A Traditional Chinese medicine for treating ischemic apoplexy |
| 03/05/2008 | CN101134085A Traditional Chinese medicine for treating apoplexy and hemiplegia |
| 03/05/2008 | CN101134082A Traditional Chinese medicine for treating early hemorrhagic apoplexy |
| 03/05/2008 | CN101134078A Medicine for treating pile |
| 03/05/2008 | CN101134076A Traditional Chinese medicine for treating apoplectic aphasia |
| 03/05/2008 | CN101134066A Technique of preparing lotus nut dropping pills for treating quick type arrhythmia |
| 03/05/2008 | CN101134060A Capsule for treating myocardial strain, stenocardia and arteriosclerosis |
| 03/05/2008 | CN101134058A Health products having blood fat and blood pressure reducing functions and manufacturing method thereof |
| 03/05/2008 | CN101134055A Moxa cone for treating hemorrhoid |
| 03/05/2008 | CN101134042A Notoginsenoside pharmaceutical composition and method for preparing the same and use thereof |
| 03/05/2008 | CN101134039A Soya bean lecithin powder medicine and method for preparing the same |
| 03/05/2008 | CN101134032A Compound preparations for treating hypertension and method for preparing the same |
| 03/05/2008 | CN101134030A Gingkgo genin flavone soft capsule and method for preparing the same |
| 03/05/2008 | CN101134029A Use of alvianolic acid B salt as Na+/K+-ATP enzyme inhibitor |
| 03/05/2008 | CN101134027A Oral liquid for preventing and relieving cardiovascular and cerebrovascular diseases |
| 03/05/2008 | CN101134025A Hydrochloric acid flunarizine dropping pills |
| 03/05/2008 | CN101134023A Hydrochloric acid terazosin oral cavity disintegrating lyophilized tablets and method for preparing the same |
| 03/05/2008 | CN101134018A Fenofibrate pellet and method for preparing the same |
| 03/05/2008 | CN101133787A Wilding synthesized black rice black soya bean compressed food granules beverage and method of processing the same |
| 03/05/2008 | CN100372944C The use of PDE4D in the screening for medicaments against atherosclerosis |
| 03/05/2008 | CN100372849C Pyrrolo pyrimidine compounds as inhibitor of cysteine protease |
| 03/05/2008 | CN100372848C Spiroazacyclic compounds as monoamine receptor modulators |
| 03/05/2008 | CN100372845C Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 03/05/2008 | CN100372572C Recombinant plasmid with human thymosin Beta-4gene |
| 03/05/2008 | CN100372567C Thrombin derived peptides for promoting cardiac tissue repair |
| 03/05/2008 | CN100372549C Method for preparing powder of red sage root with high content in use for administration through vein |
| 03/05/2008 | CN100372548C Compound capsule with omega-3 fatty acid as main component and its preparing process |
| 03/05/2008 | CN100372547C Use of compound red-rooted salvia drop pills in preparation of mass cell degranulation prohibiting drug |
| 03/05/2008 | CN100372534C Torasemide freeze-drying preparation and prepration method |
| 03/05/2008 | CN100372531C Percutaneous absorption preparations containing 3-methyl-phenyl-2-pyrazolin-5-one |
| 03/05/2008 | CN100372528C Ginkgolide B soft capsule and its preparing method |
| 03/05/2008 | CN100372525C Frozen dry powder injection of composite salvia miltiorrhiza and its preparation |
| 03/05/2008 | CN100372520C Preparing method of scalded leech medicine granule |
| 03/04/2008 | US7339047 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases |
| 03/04/2008 | US7339038 Heparanase specific molecular probes and their use in research and medical applications |
| 03/04/2008 | US7339023 Angiogenesis inhibitors, antitumor agents |
| 03/04/2008 | US7338965 Enzyme inhibitors of beta-secretase which cleaves amyloid precursor protein present in Alzheimer's disease; Trisomy 21 (Down's Syndrome); Hereditary Cerebral Hemorrhage; cognition activators; Parkinson's disease |
| 03/04/2008 | US7338963 blood coagulation factor (trypsin-like serine protease enzymes) inhibitor; 3-(4-methoxy-phenyl)-5-[4-(2-oxo-2H-pyridin-1-yl)-phenyl]-3,5,6,7-tetrahydro-[1,2,3]triazolo4,5-c]pyridin-4-one; anticoagulant; cardiovascular thromboembolic disorder transient ischemic attack, stroke, atherosclerosis |
| 03/04/2008 | US7338960 {[2-Methyl-4-({[4'-(trifluoromethyl)-3-biphenylyl]methyl}thio)phenyl]oxy}acetic acid; adipogenic signalling cascade and lipid homeostasis; increase High Density Lipoproteins; hypotensive agent; Syndrome X, obesity, insulin resistance, cardiovascular disorder |
| 03/04/2008 | US7338959 N2-isopropyl-N5,1-dimethyl-N5-[2-({4-[(methylsulfonyl)methyl]phenyl}amino)pyrimidin-4-yl]-1H-benzimidazole-2,5-diamine; vascular endothelial growth factor (VEGF) receptor-2 and tyrosine kinase containing Ig and EGF homology domains (TIE) -2 inhibitor; antiproliferation and antihypoxic agent |
| 03/04/2008 | US7338653 Amino-terminally truncated MCP-2 as chemokine antagonists |
| 02/28/2008 | WO2008024390A2 2- (pyrazin-2-yl) -thiazole and 2- (1h-pyraz0l-3-yl) -thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other disorders |
| 02/28/2008 | WO2008024029A1 Substituted azepino[4,3-b]indoles, pharmacological composition and a method for the production and use thereof |
| 02/28/2008 | WO2008023784A1 Agent for amelioration of ophthalmic circulatory disorder |
| 02/28/2008 | WO2008023608A1 Lipid-metabolism-ameliorating agent |
| 02/28/2008 | WO2008023157A1 Nitrogen containing heterocyclic compounds useful as m3-receptor modulators |
| 02/28/2008 | WO2008023003A1 Drug combinations for treating airway diseases |
| 02/28/2008 | WO2008022974A2 Anti-diabetes composition containing chicoric acid and/or one of the metabolites thereof |
| 02/28/2008 | WO2008022801A1 Method for the manufacture of a medicament for treating hemorrhagic stroke |
| 02/28/2008 | WO2008000744A3 2-0'-methyladen0sine derivatives and their use as agonists or antagonists of an adenosine receptor |
| 02/28/2008 | WO2007146900A3 Antihypertensive therapy method |
| 02/28/2008 | WO2007141593A3 Process for the preparation of metoprolol and its salts |
| 02/28/2008 | WO2007016095A3 Cyclooxygenase-2 selective inhibitor compounds comprising nitric oxide enhancing groups, compositions and methods of use |
| 02/28/2008 | US20080051454 Compositions and methods for transient receptor potential vanilloid (TRPV) channel mediated treatments |
| 02/28/2008 | US20080051449 Preparation of atorvastatin calcium form vi and compositions thereof |
| 02/28/2008 | US20080051448 Stabilized extended release pharmaceutical compositions comprising an amg-coa reductase inhibitor |
| 02/28/2008 | US20080051438 Preventive/Therapeutic Compositions Useful for Treating Cardiovascular Diseases |
| 02/28/2008 | US20080051436 Use of Acylaminothiazole Derivatives as Therapeutic Agents |
| 02/28/2008 | US20080051434 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 02/28/2008 | US20080051421 pyrazolo- and imidazo-pyrimidine derivatives; for anxiety and pain, neurodegenerative disorders; 8-Pyridin-4-yl-4-trifluoromethyl-2-(4-trifluoromethyl-phenyl)-imidazo[1,5-a]pyrimidine |
| 02/28/2008 | US20080051417 Uses of selective cyclooxygenase-1 inhibitors |
| 02/28/2008 | US20080051373 Parenteral preparations of GI-safer phospholipid-associated anti-inflammatories and methods of preparation and use |
| 02/28/2008 | US20080051356 Truncated 24kDa basic fibroblast growth factor |
| 02/28/2008 | US20080051341 Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome |
| 02/28/2008 | US20080051338 98 Human Secreted Proteins |
| 02/28/2008 | US20080051323 Chloroquine drug compositions and methods for their synthesis |
| 02/28/2008 | US20080051321 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 02/28/2008 | US20080050716 Methods for preserving organs and tissues |
| 02/28/2008 | US20080050461 Nanoparticulate compositions of angiogenesis inhibitors |
| 02/28/2008 | US20080050457 Ginkgo Biloba Extract And Method For Producing The Same |
| 02/28/2008 | US20080050437 a time-release composition comprising antithrombins such as (2S)-1-[(2R)-2-[3-chloro-5-(difluoromethoxy)phenyl]-2-hydroxyacetyl]-N-[[4-[(Z)-N'-methoxycarbamimidoyl]phenyl]methyl]azetidine-2-carboxamide, hydroxy propyl methyl cellulose and sodium stearyl fumarate as a lubricant; cardiovascular disorder |
| 02/28/2008 | US20080050432 Combined Pharmaceutical Formulation with Controlled-Release Comprising Dihydropyridine Calcium Channel Blockers and HMG-COA Reductase Inhibitors |
| 02/28/2008 | US20080050429 Low flush niacin formulation |
| 02/28/2008 | US20080050388 Specified complementary determining region (CRD) amino acid sequences; specific binding activity for a cryptic collagen epitope; angiogenesis inhibition, antimetastasis, and tumor-targeted therapy uses |
| 02/28/2008 | US20080050369 Therapeutic applications of T-BAM (CD40L) technology to treat diseases involving smooth muscle cells |
| 02/28/2008 | US20080050351 Gene Therapy Approaches to Supply Apolipoprotein A-I Agonists and Their Use to Treat Dyslipidemic Disorder |
| 02/28/2008 | US20080050349 Cell based therapy for the pulmonary system |
| 02/28/2008 | US20080050348 Method and composition for repairing heart tissue |
| 02/28/2008 | US20080050347 Stem cell therapy for cardiac valvular dysfunction |
| 02/28/2008 | US20080050315 Diagnostics and Therapeutics for Diseases Associated with Protein Kinase, Cgmp-Dependent, Type I (Prkg1) |
| 02/28/2008 | US20080050314 Diagnostics and Therapeutics for Diseases Associated With Glycogen Synthase Kinase 3 Beta (Gsk3b) |
| 02/28/2008 | DE602004007105T2 Zusammensetzung zur behandlung von gastrointestinalen störungen Composition for the treatment of gastrointestinal disorders |
| 02/28/2008 | CA2661496A1 Pharmaceutical combinations for the treatment of respiratory diseases |
| 02/28/2008 | CA2661373A1 Lipid-metabolism-ameliorating agent |
| 02/28/2008 | CA2661329A1 Anti-diabetes composition containing chicoric acid and/or one of the metabolites thereof |
| 02/28/2008 | CA2661017A1 Organic compounds |
| 02/27/2008 | EP1892299A2 Sense mRNA therapy |
| 02/27/2008 | EP1892293A1 Transcription factor decoy |
| 02/27/2008 | EP1892251A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/27/2008 | EP1892250A2 CYR61 compositions and methods |
| 02/27/2008 | EP1892241A1 Novel piperidine derivative |
| 02/27/2008 | EP1891971A1 Medicinal composition for ameliorating or treating glucose intolerance, borderline diabetes, insulin resistance and hyperinsulinemia containing hypoglycemic agent |
| 02/27/2008 | EP1891948A1 Treatment of neurological and neuropsychological disorders |
| 02/27/2008 | EP1891109A1 Cardiovascular disease therapies |
| 02/27/2008 | EP1891055A2 Process for the preparation of losartan potassium |
| 02/27/2008 | EP1891008A1 Oxindoles as kinase inhibitors |